Artelo Biosciences, Inc. (ARTL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Artelo Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.22x | -6.26x | -8.03x | -2.44x | -6.87x | -2.29x |
| P/B Ratio | -2.26x | 21.52x | 6.35x | 1.27x | 4.24x | 2.75x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 0.17x | 1.44x | 8.51x | 18.36x | 19.61x | 4.65x |
| Quick Ratio | 0.17x | 1.44x | 8.51x | 18.36x | 19.61x | 4.65x |
| Leverage | ||||||
| Debt/Equity | -0.54x | 0.04x | 0.00x | 0.00x | 0.01x | 0.00x |
YoY = year-over-year change. Source: FMP..